The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Clinical scenarios that should prompt referral to a specialized MDS center
Lynette Chee, MBBS, PhD, The Royal Melbourne Hospital/ Peter MacCallum Cancer Centre, Melbourne, Australia, describes clinical scenarios that should prompt referral to a specialized myelodysplastic syndrome (MDS) center. She discusses the importance of using newer prognostic scoring systems, as they can help identify higher-risk patients who may benefit from referral to a specialized center for consideration of transplant. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
